ZBIOZenas BioPharma, Inc.

$26.87+11% 1Y

Is it growing?

Watch

Revenue shrinking (−93% year on year). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data
Revenue trend−93% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ZBIO growing?

Years of annual history on file
3

Years of annual history on file · FY2023 to FY2025, as filed

Details›
Revenue FY2023
$50M
Revenue FY2024
$5.0M
Revenue FY2025
$10M

Annual income statements as filed with the SEC.

On our screens:Most shorted stocks